9VJ-60048-98450
3 vaccinations
2 coded responses
2 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 882 / NM
- Registered
- 2022-02-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
A9P-16268-90578
Child or adolescent in my care · Male · 2022-02-07
Timeline
-
2021-01-25
Dose 1 — Moderna
-
2021-02-24
Dose 2 — Moderna
-
2021-11-03
Dose 3 — ModernaCo-administered: Flu
-
2022-02-07
Registered in v-safe
-
2022-02-08
Survey response — 3 months, dose 3MedDRA: Conjunctivitis, Eye pain, Fatigue, Gait inability, Lymphadenopathy, Migraine, Muscular weakness, Nausea, Pain, Rash, Urinary incontinence, Vision blurred, Vomiting — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Nausea, vomiting pain Swelling in multiple lymph node areas over several months Inability to walk or control bladder. Extreme fatigue, pain, weakness in legs. Polka dotted rash on legs Severe migraines Eyes conjunctivitis, blurred vision, eye pain MMedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-02-09
Call successfulParticipant prefers to complete VAERS report online
-
2022-11-10
Survey response — 12 months, dose 3MedDRA: Amnesia, Aphasia, Balance disorder, Brain fog, Dizziness, Fatigue, Memory impairment, Migraine, Muscular weakness, Neurological symptom, Pain in extremity — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Experiencing multiple neurological symptoms. Loss of balance, extreme pain in limbs, extreme weakness in muscles, fatigue, brain fog, forget words, long and short-term memory problems, extreme migraines, dizziness.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-10
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-11-11
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Moderna | No |
| 2 | 2021-02-24 | Moderna | No |
| 3 | 2021-11-03 | Moderna | Flu |
Call center
2 call center cases
2 successful
Free text
Release 11 — 3 months, dose 3
Symptoms: Nausea, vomiting pain Swelling in multiple lymph node areas over several months Inability to walk or control bladder. Extreme fatigue, pain, weakness in legs. Polka dotted rash on legs Severe migraines Eyes conjunctivitis, blurred vision, eye pain M cut off by CDC
Release 12 — 12 months, dose 3
Symptoms: Experiencing multiple neurological symptoms. Loss of balance, extreme pain in limbs, extreme weakness in muscles, fatigue, brain fog, forget words, long and short-term memory problems, extreme migraines, dizziness.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Amnesia | · | · | ✓ |
| SD | Aphasia | · | · | ✓ |
| SD | Balance disorder | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Conjunctivitis | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Eye pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gait inability | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Neurological symptom | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Urinary incontinence | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release